Ahammune Biosciences: Financial Breakdown
Decoding financial health metrics of Ahammune Biosciences
- Total Revenue₹36.0 Lakh28%
Prev. FY
- Total Expenses₹89.0 Lakh-49%
Prev. FY
- Profit After Tax₹-53.0 Lakh63%
Prev. FY
- Total Assets₹11.3 Cr+-6%
Prev. FY
- Net Profit Margin-1.5%70%
Prev. FY
FAQs on Financials of Ahammune Biosciences
No. In FY23, Ahammune Biosciences reported a net loss of ₹53.0 Lakh, so it was not profitable.
Ahammune Biosciences's revenue grew 28.6% year-on-year, from ₹28.0 Lakh in FY22 to ₹36.0 Lakh in FY23.
In FY23, Ahammune Biosciences posted revenue of ₹36.0 Lakh (up 28.6% YoY) and a net loss of ₹53.0 Lakh. Explore the full financials of Ahammune Biosciences here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links

